Company page

Noxopharm Ltd.

Noxopharm Ltd. is a public company listed on the Australian market under the ticker NOX, with a market capitalization of approximately AUD 16.58 million. The company focuses on developing innovative therapies for cancer and other serious diseases. Noxopharm is dedicated to advancing its research and clinical programs to improve patient outcomes.